Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 26
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00434473 | IMPACTS Trial: Investigation of the Modulation of Phospholipase in Acute Chest Syndrome | ||
| NCT02074020 | CHABLIS-SC2: A Study of the Efficacy and Safety of Subcutaneous Blisibimod in Subjects With Systemic Lupus Erythematosus With or Without Nephritis | ||
| NCT00455546 | PLASMA Trial: A Dose-Response Study of A-002 In Subjects With Stable Coronary Artery Disease | ||
| NCT01598857 | BIANCA-SC: A Study of the Efficacy, Safety, and Tolerability of Blisibimod in Addition to Methotrexate During Induction of Remission in Subjects With ANCA-Associated Small Vessel Vasculitis | ||
| NCT00743925 | FRANCIS-ACS Trial: A Study of the Safety and Efficacy of A 002 in Subjects With Acute Coronary Syndromes | ||
| NCT01130246 | VISTA-16 Trial: Evaluation of Safety and Efficacy of Short-term A-002 Treatment in Subjects With Acute Coronary Syndrome | ||
| NCT01522196 | A Study of Varespladib Infusion in Subjects With Sickle Cell Disease. | ||
| NCT02052219 | BRILLIANT-SC: A Study of the Efficacy and Safety of Blisibimod Administration in Subjects With IgA Nephropathy | ||
| NCT00533039 | sPLA2 Inhibition to Decrease Enzyme Release After PCI Trial | ||
| NCT00449904 | Open-Label Phase III Long-Term Safety Trial of Liprotamase | ||
| NCT02734810 | SIMPLICITY: Studying Impacts on Malabsorption With Liprotamase in Cystic Fibrosis | ||
| NCT01305746 | A Trial for Subjects With Systemic Lupus Erythematosus Who Have Completed Protocol AN-SLE3321 | ||
| NCT02514967 | CHABLIS7.5: A Study of the Efficacy and Safety of Subcutaneous Blisibimod in Subjects With Systemic Lupus Erythematosus With or Without Nephritis | ||
| NCT00500084 | Phase III ALTU-135 CP Safety Trial | ||
| NCT01162681 | PEARL-SC Trial: A Study of the Efficacy, Safety, and Tolerability of A 623 Administration in Subjects With Systemic Lupus Erythematosus | ||
| NCT01609452 | MONICA-SC: A Study to Evaluate the Efficacy, Safety and Tolerability of Blisibimod (A-623) Administration in Subjects With ITP | ||
| NCT02823964 | EASY: Extended Access to Sollpura Over Years | ||
| NCT02062684 | BRIGHT-SC: Blisibimod Response in IgA Nephropathy Following At-Home Treatment by Subcutaneous Administration | ||
| NCT01359579 | A Study of the Pharmacokinetics and Safety of Varespladib in Subjects With Normal or Impaired Renal Function | ||
| NCT03051490 | RESULT: Reliable, Emergent Solution Using Liprotamase Treatment | ||
| NCT00095732 | Oral TheraCLEC™ - Total in Cystic Fibrosis Subjects With Exocrine Pancreatic Insufficiency | ||
| NCT00449878 | Liprotamase Efficacy Trial in Patients With Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency | ||
| NCT02279498 | SOLUTION: Study of Oral Liprotamase Unit-Matched Therapy Of Non-Porcine Origin in Patients With Cystic Fibrosis | ||
| NCT01359605 | Study to Assess the Metabolism and Elimination of [14C]-Labeled Varespladib Methyl in Healthy Male Subjects | ||
| NCT01395745 | CHABLIS-SC1: A Study of the Efficacy and Safety of Subcutaneous Blisibimod in Subjects With Systemic Lupus Erythematosus | ||
| NCT00525954 | PLASMA 2 Trial: Examination of Once Daily (QD) Dosing of A-002 In Subjects With Stable Coronary Artery Disease |
